MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance

Canadian Markets open in 4 hrs 24 mins

Merck & Co., Inc. (MRK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
62.70+0.40 (+0.64%)
At close: 4:01PM EDT
People also watch
PFEJNJBMYLLYPG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close62.30
Open62.63
Bid0.00 x
Ask0.00 x
Day's Range62.43 - 62.88
52 Week Range53.06 - 66.80
Volume8,859,276
Avg. Volume9,023,614
Market Cap171.89B
Beta0.95
PE Ratio (TTM)44.47
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.88 (2.99%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters12 hours ago

    Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

    Merck & Co's cholesterol-reducing drug Vytorin faces competition for the first time ever after two companies announced progress on their generic versions of a drug that generated more than $1 billion in sales last year. The U.S. Food and Drug Administration on Wednesday approved Impax Laboratories Inc's generic version of Vytorin, while Teva Pharmaceutical Industries Ltd launched its generic version of the drug in the United States. Impax said it will immediately start commercialization for its generic version of Vytorin.

  • Reuters13 hours ago

    FDA approves Impax generic of Merck's cholesterol drug Vytorin

    The U.S. Food and Drug Administration on Wednesday approved Impax Laboratories Inc's generic version of Merck & Co's cholesterol-reducing drug Vytorin, the first cheap competitor for a drug that in 2016 generated more than $1 billion in sales. Vytorin is a combination product that includes the drugs ezetimibe and simvastatin, sold under the brand names Zocor and Zetia. Zetia lost patent protection on Tuesday.

  • What's in Store for Merck (MRK) this Earnings Season?
    Zacks18 hours ago

    What's in Store for Merck (MRK) this Earnings Season?

    Merck & Co., Inc. (MRK) will be reporting first-quarter 2017 earnings on May 2, before market opens. Last quarter, the company delivered a positive earnings surprise of 1.14%.